Market Place
Sourcing Support
AB Science Sees 4th Positive Response In Ab8939-Venetoclax Combo
07 Jan 2026 //
GLOBENEWSWIRE
AB Science Unveils BioRxiv Paper on AB8939 for Refractory AML
15 Dec 2025 //
GLOBENEWSWIRE
AB Science Completes EUR 2.8M Private Placement
17 Oct 2025 //
GLOBENEWSWIRE
AB Science Reports Early Ph1 Data of AB8939 + Venetoclax in AML
16 Oct 2025 //
GLOBENEWSWIRE
AB Science To Host Virtual Conference On AB8939 Phase 1 Study
14 Oct 2025 //
GLOBENEWSWIRE
AB Science Wins EU Nod for Ph I/II AML Study With AB8939
30 Jul 2025 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.